Literature DB >> 16434112

Characterization of a mutation and an alternative splicing of UDP-galactose transporter in MDCK-RCAr cell line.

Mariusz Olczak1, Eduardo Guillen.   

Abstract

The UDP-galactose (UDP-Gal) transporter present in the Golgi apparatus is a member of a transporter family comprising hydrophobic proteins with multiple transmembrane domains. Co-immunoprecipitation experiments showed that the full-length UDP-Gal transporter protein forms oligomeric structures in the MDCK cell. A ricin-resistant mutant of the MDCK cell line (MDCK-RCA(r)) is deficient in galactose linked to macromolecules because of a lower UDP-Gal transport rate into the Golgi apparatus. We cloned this mutated protein and found that it contains a stop codon close to the 5' terminus of its open reading frame. We also detected a shorter splicing variant of the UDP-Gal transporter which contains a 183-nt in-frame deletion in both the wild-type and the mutant mRNA. We showed that the protein, when overexpressed, is localized in the Golgi apparatus and could partially correct the phenotype of the MDCK-RCA(r) and CHO-Lec8 mutant cell lines. The level of mRNA of the UDP-Gal transporter is much lower (25-30 copies per cell) than those of the CMP-sialic acid transporter (100 copies per cell), UDP-N-acetylglucosamine transporter (80 copies per cell), and GDP-fucose transporter (65 copies per cell). The transcript level of the shorter splicing variant of the UDP-Gal transporter is extremely rare in wild-type MDCK cells (a few copies per cell), but it is significantly increased in the mutant, RCA-resistant cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434112     DOI: 10.1016/j.bbamcr.2005.12.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  SLC35A2-CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals.

Authors:  Bobby G Ng; Paulina Sosicka; Satish Agadi; Mohammed Almannai; Carlos A Bacino; Rita Barone; Lorenzo D Botto; Jennifer E Burton; Colleen Carlston; Brian Hon-Yin Chung; Julie S Cohen; David Coman; Katrina M Dipple; Naghmeh Dorrani; William B Dobyns; Abdallah F Elias; Leon Epstein; William A Gahl; Domenico Garozzo; Trine Bjørg Hammer; Jaclyn Haven; Delphine Héron; Matthew Herzog; George E Hoganson; Jesse M Hunter; Mahim Jain; Jane Juusola; Shenela Lakhani; Hane Lee; Joy Lee; Katherine Lewis; Nicola Longo; Charles Marques Lourenço; Christopher C Y Mak; Dianalee McKnight; Bryce A Mendelsohn; Cyril Mignot; Ghayda Mirzaa; Wendy Mitchell; Hiltrud Muhle; Stanley F Nelson; Mariusz Olczak; Christina G S Palmer; Arthur Partikian; Marc C Patterson; Tyler M Pierson; Shane C Quinonez; Brigid M Regan; M Elizabeth Ross; Maria J Guillen Sacoto; Fernando Scaglia; Ingrid E Scheffer; Devorah Segal; Nilika Shah Singhal; Pasquale Striano; Luisa Sturiale; Joseph D Symonds; Sha Tang; Eric Vilain; Mary Willis; Lynne A Wolfe; Hui Yang; Shoji Yano; Zöe Powis; Sharon F Suchy; Jill A Rosenfeld; Andrew C Edmondson; Stephanie Grunewald; Hudson H Freeze
Journal:  Hum Mutat       Date:  2019-04-24       Impact factor: 4.878

2.  UDP-galactose (SLC35A2) and UDP-N-acetylglucosamine (SLC35A3) Transporters Form Glycosylation-related Complexes with Mannoside Acetylglucosaminyltransferases (Mgats).

Authors:  Dorota Maszczak-Seneczko; Paulina Sosicka; Beata Kaczmarek; Michał Majkowski; Marcin Luzarowski; Teresa Olczak; Mariusz Olczak
Journal:  J Biol Chem       Date:  2015-05-05       Impact factor: 5.157

3.  A new case of UDP-galactose transporter deficiency (SLC35A2-CDG): molecular basis, clinical phenotype, and therapeutic approach.

Authors:  K Dörre; M Olczak; Y Wada; P Sosicka; M Grüneberg; J Reunert; G Kurlemann; B Fiedler; S Biskup; K Hörtnagel; S Rust; T Marquardt
Journal:  J Inherit Metab Dis       Date:  2015-03-17       Impact factor: 4.982

4.  UDP-N-acetylglucosamine transporter (SLC35A3) regulates biosynthesis of highly branched N-glycans and keratan sulfate.

Authors:  Dorota Maszczak-Seneczko; Paulina Sosicka; Teresa Olczak; Piotr Jakimowicz; Michał Majkowski; Mariusz Olczak
Journal:  J Biol Chem       Date:  2013-06-13       Impact factor: 5.157

5.  Sequence determinants of GLUT1 oligomerization: analysis by homology-scanning mutagenesis.

Authors:  Julie K De Zutter; Kara B Levine; Di Deng; Anthony Carruthers
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

6.  Comparative analysis of involvement of UGT1 and UGT2 splice variants of UDP-galactose transporter in glycosylation of macromolecules in MDCK and CHO cell lines.

Authors:  Dorota Maszczak-Seneczko; Teresa Olczak; Livius Wunderlich; Mariusz Olczak
Journal:  Glycoconj J       Date:  2011-09-06       Impact factor: 2.916

7.  In silico analysis of the fucosylation-associated genome of the human blood fluke Schistosoma mansoni: cloning and characterization of the enzymes involved in GDP-L-fucose synthesis and Golgi import.

Authors:  Nathan A Peterson; Tavis K Anderson; Xiao-Jun Wu; Timothy P Yoshino
Journal:  Parasit Vectors       Date:  2013-07-09       Impact factor: 3.876

8.  N-acetylglucosaminyltransferases and nucleotide sugar transporters form multi-enzyme-multi-transporter assemblies in golgi membranes in vivo.

Authors:  Fawzi Khoder-Agha; Paulina Sosicka; Maria Escriva Conde; Antti Hassinen; Tuomo Glumoff; Mariusz Olczak; Sakari Kellokumpu
Journal:  Cell Mol Life Sci       Date:  2019-02-08       Impact factor: 9.261

9.  Novel Insights into Selected Disease-Causing Mutations within the SLC35A1 Gene Encoding the CMP-Sialic Acid Transporter.

Authors:  Bożena Szulc; Yelyzaveta Zadorozhna; Mariusz Olczak; Wojciech Wiertelak; Dorota Maszczak-Seneczko
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

10.  SLC35A2 Deficiency Promotes an Epithelial-to-Mesenchymal Transition-like Phenotype in Madin-Darby Canine Kidney Cells.

Authors:  Magdalena Kot; Ewa Mazurkiewicz; Maciej Wiktor; Wojciech Wiertelak; Antonina Joanna Mazur; Andrei Rahalevich; Mariusz Olczak; Dorota Maszczak-Seneczko
Journal:  Cells       Date:  2022-07-23       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.